celltiter glo luciferase based atp detection assay  (Promega)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 87

    Structured Review

    Promega celltiter glo luciferase based atp detection assay
    Celltiter Glo Luciferase Based Atp Detection Assay, supplied by Promega, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltiter glo luciferase based atp detection assay/product/Promega
    Average 87 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    celltiter glo luciferase based atp detection assay - by Bioz Stars, 2020-04
    87/100 stars

    Images

    Related Articles

    Luciferase:

    Article Title: The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition), The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
    Article Snippet: .. Cell viability was assessed using the CellTiter‐Glo luciferase‐based ATP detection assay (Promega) following manufacturer's instructions. .. CellTiter‐Glo is a homogeneous assay method based on the quantification of ATP present, an indicator of the number of metabolically active cells.

    Detection Assay:

    Article Title: The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition), The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
    Article Snippet: .. Cell viability was assessed using the CellTiter‐Glo luciferase‐based ATP detection assay (Promega) following manufacturer's instructions. .. CellTiter‐Glo is a homogeneous assay method based on the quantification of ATP present, an indicator of the number of metabolically active cells.

    Concentration Assay:

    Article Title: The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition), The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
    Article Snippet: Twenty‐four hours after seeding, medium was replaced with medium containing serial dilutions of test compound and incubated for an additional 72 h. All media contained a final DMSO concentration of 0.1% (v/v). .. Cell viability was assessed using the CellTiter‐Glo luciferase‐based ATP detection assay (Promega) following manufacturer's instructions.

    Incubation:

    Article Title: The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition), The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
    Article Snippet: Twenty‐four hours after seeding, medium was replaced with medium containing serial dilutions of test compound and incubated for an additional 72 h. All media contained a final DMSO concentration of 0.1% (v/v). .. Cell viability was assessed using the CellTiter‐Glo luciferase‐based ATP detection assay (Promega) following manufacturer's instructions.

    Metabolic Labelling:

    Article Title: The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition), The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
    Article Snippet: Cell viability was assessed using the CellTiter‐Glo luciferase‐based ATP detection assay (Promega) following manufacturer's instructions. .. CellTiter‐Glo is a homogeneous assay method based on the quantification of ATP present, an indicator of the number of metabolically active cells.

    Activity Assay:

    Article Title: The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition), The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
    Article Snippet: To evaluate the antiproliferative activity of test compounds, cells were seeded in 384‐well plates with appropriate complete medium. .. Cell viability was assessed using the CellTiter‐Glo luciferase‐based ATP detection assay (Promega) following manufacturer's instructions.

    Software:

    Article Title: The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition), The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition
    Article Snippet: Cell viability was assessed using the CellTiter‐Glo luciferase‐based ATP detection assay (Promega) following manufacturer's instructions. .. Growth inhibitory activity was evaluated at the end of incubation, comparing data for treated versus control samples, using Accelrys® Assay Explorer software.

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 87
    Promega celltiter glo luciferase based atp detection assay
    Celltiter Glo Luciferase Based Atp Detection Assay, supplied by Promega, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/celltiter glo luciferase based atp detection assay/product/Promega
    Average 87 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    celltiter glo luciferase based atp detection assay - by Bioz Stars, 2020-04
    87/100 stars
      Buy from Supplier

    Image Search Results